North America miRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Technology, and End User - ResearchAndMarkets.com
Retrieved on:
Wednesday, September 22, 2021
Biotechnology, Health, Genetics, Science, Research, MicroRNA, RNA transfection, Miravirsen, Mirna, RNA, Degenerative disease, Therapy, CAGR, Cancer, MiR-122, Phase, Genomics, Growth, Hepatitis, Cros, Technology, COVID-19, Research, Santaris Pharma, HCV, Carcinogenesis, Pet, Pharmaceutical industry, Fine chemical
The "North America miRNA Sequencing and Assay Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "North America miRNA Sequencing and Assay Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.
- The North America miRNA sequencing and assay market, by product, is segmented into library preparation and consumables.
- Based on technology, the North America miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing.
- Based on end user, the North America miRNA sequencing and assay market is segmented into research institute, academia, and CROs.